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Here we describe a case of ergotism that presented with ischemia in all four extremities. A 48-year-old man was 
admitted for pain and weakness in both upper extremities. He had a long history of migraine and had taken 3 mg 
of ergotamine daily for more than 21 years. Angiography demonstrated vasospasm involving all four extremities, 
which resolved partially following intra-arterial prostaglandin infusion. Intravenous nitroprusside was administered, and 
the patient stopped smoking and stopped taking ergotamine in an attempt to counteract the vasospasm. Follow-up 
computed tomography angiogram revealed that both brachial arteries had normalized. Thus, in this case of ergotism, 
severe vasospasm in all of the extremities was resolved with appropriate management.
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INTRODUCTION
Ergotamine has been used widely for the treatment of 
migraine, even though triptan derivatives have been 
accepted as the most effective agents for the relief of 
acute migraine attacks.
1 Ergotism is a sustained 
vasospasm induced by ergot medication, and is very 
rare, but has been observed in various situations, mainly 
as a result of ergotamine overuse,
2 idiosyncratic 
hypersensitivity reaction with therapeutic doses,
3 and 
during concomitant use of other kinds of medication.
4 
The sustained arterial spasm observed in ergotism causes 
vascular insufficiency in the extremities, which is 
characterized by pallor, coolness, numbness, and 
claudication if not treated promptly, the affected limb(s) 
may develop dry gangrene and, less commonly, suppu-
rative gangrene and sepsis.
5
To treat ergotism, it is mandatory to discontinue the 
ergotamine as well as other provocative factors, and then 
a therapeutic strategy should be established to control 
the withdrawal symptoms and migraine.
1 In cases of 
acute ergot toxicity, various levels of success have been 
reported with other treatment options, including calcium 
channel blockers, oral prazosin hydrochloride, alpha 
adrenergic blockers, systemic vasodilator therapy with 
nitroprusside, prostacyclin, and prostaglandin E.
6,7
Here we describe a patient with ergotism who pre-Journal of Clinical Neurology: Vol. 2, No. 4, 2006
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Figure 1. Angiographic findings in the upper and lower extremities. The 
proximal portions of the right (A) and left (B) brachial artery, showing the 
smoothly tapered brachial artery and diffuse “thread-like” narrowing. The distal 
portions of the right brachial artery exhibit severe vasospasm and collateral 
formation (C). Multifocal segmental narrowings are evident in both deep 
femoral arteries (D).
sented with typical angiographic findings involving both 
the upper and lower extremities, and who recovered after 
treatment, as assessed with the aid of improved vascular 
imaging.
CASE REPORT
A 48-year-old man was hospitalized for acute pain 
and weakness in both upper extremities, which had 
begun 3 days previously. He had no prior history of type 
2 diabetes mellitus, hypertension, dyslipidemia, or 
trauma. He was a current smoker consuming one pack 
daily for 30 years. Both of his upper extremities were 
pale and cold, with an absent radial pulse and markedly 
delayed capillary refill.
The patient had a long history of migraine without 
typical aura and had been taking 3 mg of ergotamine 
daily for more than 21 years, this had been prescribed 
at the local psychiatry clinic. During the week prior to 
his admission, he had increased his daily ergotamine 
intake as a result of severe headache related to 
psychological stress. Neurologic examination revealed 
abnormal sensory findings: paresthesia, numbness, and 
splitting (sharp) pain in both forearms and hands, which 
was aggravated by repeated shoulder or hand motion. 
Laboratory findings were unremarkable except for 
leukocytosis (18,400/μL).
Emergency angiography of the upper and lower 
extremities revealed diffuse spasmodic narrowing along 
the proximal portions of both brachial arteries (Fig. 1A 
and B). At the distal portions of the right brachial artery, 
severe vasospasm and collateral formations were 
observed, and the ulnar and radial arteries were poorly 
visualized (Fig. 1C). Angiography of the lower 
extremities also revealed multifocal stenoses along 
the deep and superficial femoral arteries (Fig. 1D). The 
vascularity in the left hand was improved following Jeong SY, et al. Ergotism With Ischemia In All Four Extremities 
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Figure 2. Angiographic findings in the left 
hand. The left hand exhibited poor vascular 
perfusion (A), which was markedly inproved 
after prostaglandin E1 infusion (B).
Figure 3. Follow-up upper-extremity computed tomography 
angiogram (three-dimensionally rendered). One month after 
cessation of ergotamine and nitroprusside infusion, both brachial 
arteries appeared normal.
infusion of prostaglandin E1 during the angiography 
(Fig. 2A and B), but the condition of the right upper 
extremity remained poor.
On the basis of the angiographic findings and the 
medication history, the patient was diagnosed as 
suffering from ergotism. During admission, smoking and 
all types of ergotamine and caffeine-containing drugs 
were discontinued. Intravenous nitroprusside was infused 
at a rate of 4 μg/kg/min, with itopride (50 mg) and 
propranolol (20 mg) also given twice daily. One day 
after the initiation of therapy, both radial pulses were 
palpable, and 2 days later the pain in the upper 
extremities had subsided, with minimal paresthesia. 
Nitroprusside was infused for 3 days, and then 
topiramate (50 mg) and flunarizine (10 mg) were 
started to treat withdrawal headache. Seven days after 
admission, the patient was discharged with clinical 
improvement. One month later, both brachial arteries 
appeared normal in a three-dimensional computed 
tomography angiogram (Fig. 3).
Three months later, the patient complained of 
irritability, insomnia, loss of appetite and libido, and 
psychomotor slowing that impaired his work. He was 
diagnosed with major depression by a psychiatrist, who 
prescribed paroxetine (25 mg daily). Over a period of 1 
month, the dosage was increased to 32.5 mg/day and the 
depressive symptoms slowly improved.
DISCUSSION
Ergotism, the most notable toxic effect of ergotamine, 
causes vasospasm that can effect virtually any vessel, 
including the splanchnic circulation.
1,5 In the present 
patient, angiography revealed thread-like narrowing with 
extensive collateral formation in the upper extremities, 
and segmental narrowing in the lower extremities. To 
the best of our knowledge, this is the first case of angio-
graphically proven involvement of all four extremities, Journal of Clinical Neurology: Vol. 2, No. 4, 2006
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even though the pain and weakness were confined to the 
upper extremities.
The patient had been taking 3 mg of ergotamine daily 
for more than 21 years. Although most ergot toxicity is 
associated with excessive dosing, ergotism has been 
reported after extremely small doses or therapeutic doses 
administered over a long period of time.
3,8 Furthermore, 
the patient might suffer from chronic migraine and 
therefore overuse his medication, as suggested by Silber-
stein.
9 Recent mental stress and increased intake of 
ergotamine might have provoked the ergot intoxication 
in our patient. However, the acute vascular insufficiency 
resolved rapidly after vasodilator infusion without any 
definitive complication, and the headache was managed 
with recommended conventional prophylactic regimens.
10
The patient described here suffered from psychiatric 
symptoms, and the diagnosis of depression was made 
after the treatment of acute ergotism. About 80% of 
chronic migraineurs are reported to have current 
psychiatry comorbidity.
2 It is necessary to diagnose the 
psychiatric symptoms and add an antidepressant for 
appropriate management in chronic migraineurs and 
ergotism.
We present here a patient with ergotism, which was 
resolved by the discontinuation of ergotamine and 
infusion of a vasodilator, and which was diagnosed 
initially and followed up subsequently with vascular 
imaging.
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